ArticleScientific reports2026
Effect of Al₂O₃ nanoparticle reinforcement and annealing on PMMA composite performance for prosthetic feet.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Polymethyl methacrylate (PMMA) is a biocompatible polymer widely used in prosthetic applications, yet its limited stiffness and strength restrict its performance under the cyclic loads imposed by lower limb prosthetic feet. This study investigates the combined effect of Al₂O₃ nanoparticle reinforcement and post-fabrication heat treatment on the mechanical and structural performance of PMMA-based nanocomposites for prosthetic foot applications. Nanocomposite samples containing 0, 2.5, 5, 7.5, and 10 wt% α-Al₂O₃ nanoparticles were fabricated using a silane-assisted compounding route and subsequently annealed at 80 °C, 110 °C, and 140 °C for 15 min. XRD confirmed the phase stability of the α-Al₂O₃ reinforcement and the absence of new crystalline reaction products, while scanning electron microscopy (SEM) revealed progressive densification of the particle-matrix interface up to 110 °C. The optimal formulation, P7.5 A annealed at 110 °C, in which the optimal Young's modulus and a compressive yield strength have been achieved, representing improvements of + 71.1% and + 22.2%, respectively, over neat PMMA. A finite element model (FEM) of a prosthetic foot was developed in ANSYS. FEM results showed that P7.5 A/110°C reduced total structural deformation by 40.2% relative to neat PMMA. These findings demonstrate that PMMA reinforced with 7.5 wt% Al₂O₃ and annealed at 110 °C offers a well-balanced combination of stiffness, strength, and structural safety suitable for lower limb prosthetic foot applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.